Variant report
Variant | esv1824368 |
---|---|
Chromosome Location | chr4:119340220-119387297 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:515)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr4:119340637-119341181 | GM12878 | blood: | n/a | chr4:119340900-119340911 |
2 | BATF | chr4:119346684-119346850 | GM12878 | blood: | n/a | n/a |
3 | BATF | chr4:119349910-119350272 | GM12878 | blood: | n/a | n/a |
4 | BATF | chr4:119340543-119341192 | GM12878 | blood: | n/a | chr4:119340900-119340911 |
5 | BCL11A | chr4:119345259-119345545 | GM12878 | blood: | n/a | n/a |
6 | BCL11A | chr4:119357419-119357683 | GM12878 | blood: | n/a | n/a |
7 | BCL11A | chr4:119349658-119349869 | GM12878 | blood: | n/a | n/a |
8 | BCL11A | chr4:119346839-119347055 | GM12878 | blood: | n/a | n/a |
9 | BCL11A | chr4:119366080-119366250 | GM12878 | blood: | n/a | n/a |
10 | BCL11A | chr4:119348069-119348301 | GM12878 | blood: | n/a | n/a |
11 | BCL11A | chr4:119347436-119347664 | GM12878 | blood: | n/a | n/a |
12 | BCL11A | chr4:119340615-119341149 | GM12878 | blood: | n/a | chr4:119340900-119340909 |
13 | BCL11A | chr4:119340729-119341128 | GM12878 | blood: | n/a | chr4:119340900-119340909 |
14 | BCL3 | chr4:119382599-119382899 | GM12878 | blood: | n/a | n/a |
15 | CEBPB | chr4:119340970-119341155 | Hela-S3 | cervix: | n/a | chr4:119340996-119341007 chr4:119341094-119341111 chr4:119340996-119341009 |
16 | CEBPB | chr4:119340977-119341100 | IMR90 | lung: | n/a | chr4:119340996-119341007 chr4:119340996-119341009 |
17 | CEBPB | chr4:119376054-119376279 | IMR90 | lung: | n/a | n/a |
18 | CEBPB | chr4:119340964-119341126 | HepG2 | liver: | n/a | chr4:119340996-119341007 chr4:119341094-119341111 chr4:119340996-119341009 |
19 | CEBPB | chr4:119382583-119382910 | IMR90 | lung: | n/a | chr4:119382722-119382733 |
20 | CEBPB | chr4:119351771-119351934 | K562 | blood: | n/a | n/a |
21 | CHD2 | chr4:119345423-119345555 | H1-hESC | embryonic stem cell: | n/a | n/a |
22 | CTCF | chr4:119353160-119353310 | HEK293 | kidney: | n/a | n/a |
23 | CTCF | chr4:119345270-119345538 | Fibrobl | skin: | n/a | n/a |
24 | CTCF | chr4:119368079-119368248 | K562 | blood: | n/a | n/a |
25 | CTCF | chr4:119371545-119371653 | LNCaP | prostate: | n/a | n/a |
26 | CTCF | chr4:119345300-119345450 | AG09319 | gingival: | n/a | n/a |
27 | CTCF | chr4:119371523-119371662 | LNCaP | prostate: | n/a | n/a |
28 | CTCF | chr4:119353280-119353430 | GM12874 | blood: | n/a | n/a |
29 | CTCF | chr4:119345300-119345450 | AG09309 | skin: | n/a | n/a |
30 | CTCF | chr4:119345320-119345470 | GM12871 | blood: | n/a | n/a |
31 | CTCF | chr4:119353180-119353330 | GM12869 | blood: | n/a | n/a |
32 | CTCF | chr4:119345276-119345547 | Medullo | brain: | n/a | n/a |
33 | CTCF | chr4:119345320-119345470 | GM12864 | blood: | n/a | n/a |
34 | CTCF | chr4:119345280-119345430 | GM12878 | blood: | n/a | n/a |
35 | CTCF | chr4:119345306-119345491 | Hela-S3 | cervix: | n/a | n/a |
36 | CTCF | chr4:119345320-119345470 | HVMF | connective: | n/a | n/a |
37 | CTCF | chr4:119345300-119345450 | WERI-Rb-1 | eye: | n/a | n/a |
38 | CTCF | chr4:119345380-119345530 | GM12874 | blood: | n/a | n/a |
39 | CTCF | chr4:119345380-119345530 | BJ | skin: | n/a | n/a |
40 | CTCF | chr4:119353300-119353450 | GM12872 | blood: | n/a | n/a |
41 | CTCF | chr4:119371579-119371615 | H1-hESC | embryonic stem cell: | n/a | n/a |
42 | CTCF | chr4:119345500-119345650 | SK-N-SH_RA | brain: | n/a | n/a |
43 | CTCF | chr4:119345320-119345470 | GM12866 | blood: | n/a | n/a |
44 | CTCF | chr4:119345300-119345450 | SK-N-SH_RA | brain: | n/a | n/a |
45 | CTCF | chr4:119345320-119345470 | NB4 | blood: | n/a | n/a |
46 | CTCF | chr4:119345380-119345530 | HMEC | breast: | n/a | n/a |
47 | CTCF | chr4:119345380-119345530 | HRE | kidney: | n/a | n/a |
48 | CTCF | chr4:119371640-119371790 | WERI-Rb-1 | eye: | n/a | n/a |
49 | CTCF | chr4:119345320-119345470 | HA-sp | spinal cord: | n/a | n/a |
50 | CTCF | chr4:119345290-119345507 | GM12891 | blood: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:119199281..119200962-chr4:119368800..119371509,2 | MCF-7 | breast: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-NDST3-3 | chr4:119349734-119350000 | XLOC_003661 |
2 | lnc-NDST3-3 | chr4:119350138-119350584 | XLOC_003661 |
3 | lnc-NDST3-3 | chr4:119348948-119349038 | XLOC_003661 |
No data |
No data |
Variant related genes | Relation type |
---|---|
CEP170P1 | TF binding region |
ENSG00000269893 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4001536 | chr4:119340269-119340270 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
2 | rs536136800 | chr4:119340287-119340288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs549321029 | chr4:119340318-119340319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569387784 | chr4:119340321-119340322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs557098596 | chr4:119340399-119340400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs570594333 | chr4:119340403-119340404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs200318414 | chr4:119340470-119340471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs71608374 | chr4:119340504-119340505 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs185721854 | chr4:119340511-119340512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs71608375 | chr4:119340514-119340515 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs573383062 | chr4:119340518-119340519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs535811268 | chr4:119340553-119340554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1843662 | chr4:119340679-119340680 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576989188 | chr4:119340691-119340692 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs4001513 | chr4:119340692-119340693 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs544615123 | chr4:119340718-119340719 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs200844818 | chr4:119340740-119340741 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs202009712 | chr4:119340785-119340786 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs4001514 | chr4:119340806-119340807 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs3879779 | chr4:119340827-119340828 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577866754 | chr4:119340863-119340864 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs540433388 | chr4:119340874-119340875 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558983868 | chr4:119340901-119340902 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs539485747 | chr4:119340912-119340913 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs3879780 | chr4:119340936-119340937 | Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs3879781 | chr4:119340937-119340938 | Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs192012028 | chr4:119340942-119340943 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs550647264 | chr4:119340963-119340964 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570763228 | chr4:119340991-119340992 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs201615377 | chr4:119341009-119341010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs539602320 | chr4:119341029-119341030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs546829813 | chr4:119341037-119341038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs566940201 | chr4:119341040-119341041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535601695 | chr4:119341059-119341060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555714573 | chr4:119341143-119341144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs575592310 | chr4:119341151-119341152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs3870828 | chr4:119341156-119341157 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs538529656 | chr4:119341163-119341164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs558124367 | chr4:119341178-119341179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577928740 | chr4:119341241-119341242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs113971542 | chr4:119341327-119341328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs4001521 | chr4:119341364-119341365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540394563 | chr4:119341382-119341383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs144803899 | chr4:119341585-119341586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560336899 | chr4:119341606-119341607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs71608377 | chr4:119341610-119341611 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
47 | rs541595644 | chr4:119341623-119341624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs114321375 | chr4:119341663-119341664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs530377322 | chr4:119341792-119341793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs550560351 | chr4:119341803-119341804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Autism | 19246517 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:119339200-119340600 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr4:119340600-119340800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr4:119340600-119341000 | Active TSS | Osteobl | bone |
4 | chr4:119340800-119345400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr4:119344200-119345600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
6 | chr4:119345400-119345600 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
7 | chr4:119345400-119345800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr4:119345400-119345800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
9 | chr4:119345400-119345800 | Enhancers | Dnd41 | blood |
10 | chr4:119345600-119345800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr4:119346200-119347000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr4:119355000-119356200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
13 | chr4:119355200-119355600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
14 | chr4:119356000-119356800 | Enhancers | Fetal Muscle Leg | muscle |
15 | chr4:119363400-119363800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
16 | chr4:119363400-119363800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
17 | chr4:119378600-119379400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
18 | chr4:119382400-119382800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
19 | chr4:119386800-119387200 | Enhancers | NHDF-Ad | bronchial |
20 | chr4:119386800-119387400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
21 | chr4:119387200-119387600 | Weak transcription | NHDF-Ad | bronchial |